|
|
Home |
Newsletter
| Pamphlet | News and Events |
Patient
Resources |
|
Bedroom Talk |
Books and
Videos |
Letters |
Articles of
Interest |
Links |


Chronic Pain Fact Sheet
by Marcia E. Bedard, PhD
In past months, a growing amount of media attention has
been given to the unspeakable suffering of millions of Americans with
incurable conditions causing severe chronic pain. In addition to
articles in the popular press and segments on network television, the
Internet is an increasingly rich source of information on this topic.
Yet the agonizing pain of millions of chronic pain patients remains
untreated. This is largely because the nation's War on Drugs has
created a climate of fear among patients and health professionals
alike — fear of using strong opioid medications which are often the
only way to relieve severe pain when all other treatments have failed.
This fact sheet is intended to debunk some of the myths
that fuel this unreasonable fear, and is being sent to legislators,
patients, and health professionals throughout the nation. It will
also enable members of the press to have quick access to credible
facts about chronic pain. Although this fact sheet shows the
devastating effects on physical and mental health when severe pain
goes untreated, as well as the profound impact on the economy, there
is no way to measure the "bankruptcies of the heart" that invariably
accompany this condition. Yet the steady erosion of the quality of
life for millions of pain patients and their families — as they
struggle with divorce, poverty, homelessness, despair, and often
suicide — is the real tragedy here.
FACT SHEET ON
CHRONIC NONMALIGNANT PAIN (CNP)
• CNP, pain that lasts six months or more and does not
respond well to conventional medical treatment, affects more people
than any other type of pain. Thirty-four million Americans suffer
from chronic pain, and most are significantly disabled by it,
sometimes permanently. (1, 2, 15)
• The economic impact of CNP is
staggering. Back pain, migraines, and arthritis alone account for
medical costs of $40 billion annually, and pain is the cause of 25% of
all sick days taken yearly. The annual total cost of pain from all
causes is estimated to be more than $100 billion.
(2, 4, 15)
• Despite the magnitude of suffering, CNP remains
grossly undertreated in most patients. The reasons for this are: the
low priority of pain relief in our health care system; lack of
knowledge among both health professionals and consumers about pain
management; exaggerated fears of opioid side effects and addiction;
and health professionals' fear of medical board and DEA scrutiny, even
when controlled substances are used appropriately for pain relief.
(2, 13, 14, 15)
• Contrary to common fears,
numerous studies have shown addiction is extremely rare in pain
patients taking opioid drugs, even in patients with histories of drug
abuse and/or addiction. CNP patients will develop a physical
dependence on opioid drugs, but this is not the same thing as
addiction, which is an aberrant psychological state.
(2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 13, 14)
• Unrelieved pain has many
negative health consequences including, but not limited to: increased
stress, metabolic rate, blood clotting and water retention; delayed
healing; hormonal imbalances; impaired immune system and
gastrointestinal functioning; decreased mobility; problems with
appetite and sleep, and needless suffering. CNP also causes many
psychological problems, such as feelings of low self-esteem,
powerlessness, hopelessness, and depression.
(12, 15, 16, 18, 19)
• Undertreatment of CNP often
results in suicide. In a recent survey, 50% of CNP patients had
inadequate pain relief and had considered suicide to escape the
unrelenting agony of their pain. Unrelieved pain also leads to
requests for physician-assisted suicide, another indicator of pain's
harsh impact on the quality of life of many patients and their
families. (7, 8, 13, 14, 15, 16)
• Discrimination against CNP
patients is pervasive in the American health care system. Women,
racial/ethnic minorities, children, the elderly, worker's compensation
patients, and previously disabled patients (e.g., those with cerebral
palsy, or who are deaf, blind, amputees, survivors of childhood polio,
etc.) are at great risk for undertreatment of their pain, even though
patients belonging to one or more of these groups are the vast
majority of all CNP patients. (2, 13, 17)
•
CNP patients with severe, unrelenting pain from
permanent structural damage to the neurologic or musculo-skeletal
systems are often subjected to expensive and unnecessary surgeries and
other painful invasive procedures. Arachnoiditis and reflex
sympathetic dystrophy are the most common causes of severe CNP. Other
common causes include: post-trauma, adhesions, systemic lupus,
headaches, degenerative arthritis, fibromyalgia, and neuropathies.
(8, 15, 18, 19)
Source documents:
| 1. |
American
Chronic Pain Association. "Coping with Chronic Pain." 1995. |
| 2. |
Brownlee,
Shannon, and Joannie M. Schrof. "The Quality of Mercy."
U.S. News and World Report, March 17, 1997: 55-57, 60-62, 65,
67. |
| 3. |
Pasero,
Christine L., R.N., B.S.N., and Margo McCaffery, R.N., M.S.,
F.A.A.N. "Pain Control." American Journal of Nursing. Vol. 97,
No. 6., June, 1997: 20-21. |
| 4. |
American
Academy of Pain Medicine and American Pain Society. "The Use of
Opioids for the Treatment of Chronic Pain." Clinical Journal of
Pain, Vol. 13, March, 1997: 6-8. |
| 5. |
Medina J.L.,
M.D., and S. Diamond, M.D. "Drug Dependency in Patients with
Chronic Headache." Headache, 1977, Vol. 17: 12-14. |
| 6. |
Porter J.,
M.D. and H. Jick, M.D. "Addiction Rare in Patients Treated with
Narcotics." New England Journal of Medicine 1980, Vol. 302: 123. |
| 7. |
Hitchcock,
Laura S., Ph.D., et al. "The Experience of Chronic Nonmalignant
Pain." Journal of Pain and Symptom Management, Vol. 9, No. 5,
July 1994: 312-318. |
| 8. |
Tennant,
Forest, M.D., Dr. P.H., and Harvey Rose, M.D. "Guidelines for
Opioid Treatment of Stage III Intractable Pain." California Task
Force on Opined Treatment of Stage III Intractable Pain. January
1, 1997. Research Center for Dependency Disorders and Chronic
Pain Community Health Projects Medical Group, West Covina, CA |
| 9. |
Zenz, Michael
M.D., et al. "Long-Term Oral Opioid Therapy in Patients With
Chronic Nonmalignant Pain," Journal of Pain and Symptom
Management, Vol. 7, No. 2, February 1992: 69-77. |
| 10. |
Friedman,
David P., Ph.D. "Perspectives on the Medical Use of Drugs of
Abuse." Journal of Pain and Symptom Management, Vol. 5, No. 1 (Suppl.)
February 1990: S2-S5. |
| 11. |
Portenoy,
Russell K., M.D. "Chronic Opioid Therapy in Nonmalignant Pain."
Journal of Pain and Symptom Management, Vol. 5, No. 1 (Suppl)
February 1990: S46-S62. |
| 12. |
Dellasega and
Keiser. "Pharmacologic Approaches to Chronic Pain in the Adult."
Nurse Practitioner. Vol. 22, No. 5, May 1997: 20-25. |
| 13. |
Medical Board
of California. "Prescribing for Pain Management." May 6, 1996. |
| 14. |
California
Board of Pharmacy. "Health Notes: Pain Management." 1996. |
| 15. |
Canine,
Craig. "Pain, Profit, and Sweet Relief." Worth. March, 1997:
79-82, 151-157. |
| 16. |
Liebeskind,
J.C. "Pain Can Kill." Pain, Vol. 44, No. 1, January 1991: 3-4. |
| 17. |
Morse, T.B.
"America's War on the Disabled." Albuquerque, NM: 60's Press. |
| 18. |
National
Institute of Arthritis and Musculoskeletal and Skin Diseases.
"Scientific Workshop Summary: The Neuroscience and Endocrinology
of Fibromyalgia." July 1996. Bethesda, MD. |
| 19. |
Davis, Nadyne,
et al. (eds.). "Third Annual Fibromyalgia Research Conference."
February 1994. Inland Northwest Fibromyalgia Association.
Spokane, WA 99206 |
Marcia E. Bedard, PhD, is a professor emeritus for
California State University, Fresno, CA. Printed with
permission of the author.
Return
to Articles of Interest
|